Kawasaki Disease
Kawasaki Disease
Kawasaki Disease
Department of Pediatrics
Kawasaki
Disease
JI HENARES | JI FAURA | PGI TORCITA | PGI
DUENAS
CASE OVERVIEW
01 02 03
History of Approach to
The Patient
Present Illness Diagnosis
04 05
Course in the Wards Case Discussion
01
The Patient
General Data
Age: 2 years & 6 months old
Gender: Male
Date of Birth: October 9, 2021
(-) pallor
(-) hematoma or bruises
(-) jaundice
SKIN (+) perianal desquamation
(+) edema hands and feet
(+) maculopapular rash trunk, back and
extremities
(-) palpitations
CARDIOVASCULAR (-) cyanotic episodes
(-) fainting spells
(-)changes in sensorium
(-) convulsions
NERVOUS/BEHAVIORAL (-) tremors
(-) loss of consciousness
Motor Adaptive
Able to run well, climbs furniture Able to draw circles and scribble
and open doors on paper
Language Social
Able to name objects and body Prefers to eat with a spoon
parts, name pictures, unassisted, helps to undress, listens
communicates wants/needs with to others talk and plays with other
one word children
PHYSICAL
EXAMINATIO
N
Physical Examination
Extremities Genitalia
● Maculopapular
rash ● Perianal
● Skin is warm to Desquamations
touch ● Shaft at midline
● Edema of ● Meatus at midline
Maculopapular ● Fully descended
rashhands and Testis
feet
● Full pulses
● CRT <2s
SALIENT POINTS
HISTORY PE
● Remittent Fever not relieved with Bilateral conjunctivitis with limbal
paracetamol sparing
● Nonpruritic maculopapular rash and Erythema and cracking of lips
conjunctival erythema Maculopapular rash
Edema of hands and feet
Unilateral cervical LAD 2cm
03
Approach to
Diagnosis
Algorithm
2 y.o/M
CC: Fever
Infectious Non-infectious
Acquired Inflammatory
Bacterial Viral Autoimmune Disease
Syndrome
Scarlet Fever Dengue Systemic Idiopathic Juvenile Arthritis
Kawasaki Disease
Rule in Rule out Rule in Rule out Rule in Rule out (+) Fever
(+) Fever (+) bilateral (+) Fever (+) perineal (+) bilateral conjunctival injection
Age conjunctival (+) desquamation (+) Fever (+) unilateral (+) non-tender unilateral
injection maculopapular (+) unilateral Age cervical lymphadenopathy
(+) non-tender rash cervical (+) redness of lymphadenopathy (+) maculopapular rash
unilateral (+) bilateral lymphadenopathy the white of (+) edema of (+) edema of hands and feet
lymphadenopathy conjunctival (+) edema of the eyes hands and feet (+) perineal desquamation
(+) perineal injection hands and feet (+) rash (+) Erythema and
desquamation (+) Cracked lips cracked lips
(+) edema of (-) joint pain and
hands and feet swelling
(+) maculopapular
rash
(-) strawberry
tongue
04
Course in the
Wards
HOSPITAL DAY 0 4/16/24 PLANS LABS
UA
PS, HAZY, 6.0, 1.010, pus 3-6, rbc 2-4,
protein 2+, bilirubin 2+ ketones 5 mg/dl,
few squamous, few bacteria - Sterile
pyuria
>Admit at MISC 1
> TPR q4h and record CRP 695.4 mg/dL
1 2 3
● Fever and other acute signs of ● Fever and other acutes signs have ● All clinical signs have
illness abated disappeared
● Last 1-2 weeks ● Desquamation, thrombocytosis, ● Until ESR returns to normal
development of CAA ● 6-8 weeks after onset
● Last about 3 weeks
DIAGNOSTICS
Leukocytosis with neutrophilia and immature Hypoalbuminemia
forms Hyponatremia
Elevated erythrocyte sedimentation rate Thrombocytosis after week 1
Elevated C-reactive protein Sterile pyuria
Anemia Elevated serum glutamyl transpeptidase
Abnormal plasma lipids Pleocytosis of cerebrospinal fluid
Leukocytosis in synovial fluid
2D
Echocardiogram
● Most commonly affected : LAD,
RCA; Circumflex L MCA may also be
involved
● Done at time of diagnosis, 2 weeks
and 6-8 weeks
https://pedecho.org/library/chd/kawasaki-disease
2D
Echocardiogram
● Z score LAD >2.5mm
● Z score RCA >2.5mm
● Coronary artery diameter
○ > 3 mm in children <5 years
○ > 4 mm in children ≥ to 5 years
● Lumen diameter ≥1.5 times adjacent
segment
● Coronary lumen is clearly irregular
https://pedecho.org/library/chd/kawasaki-disease
KOBAYASHI RISK SCORING
ATYPICAL VS INCOMPLETE KD
Atypical Incomplete
5 or more days of fever unexpected fever for 5 or more days
Large or Numerous
require addition of other antiplatelet agents or
Aneurysm
anticoagulants
Acute Thrombosis
thrombolytic therapy
Patient undergoing long-term aspirin therapy should receive annual influenza vaccination to
reduce the risk of Reye syndrome
PROGNOSIS
● Vast majority return to normal health, as timely treatment reduces risk of CAA
● Acute KD recurs in 1-3% cases
● Patients with CAA prognosis depends on severity
○ 50% of coronary artery aneurysm regress to normal lumen diameter by 1-2 yrs
after illness
○ Published fatality rates <1.0%
Reference: